image
DEUTSCHLAND BIOTECHNOLOGIE BIONTECH
FILE - In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection. The first of four experimental COVID-19 vaccines being tested by Pfizer and its German partner BioNTech showed encouraging results in very early testing of 45 people, the companies said Wednesday, July 1, 2020. (University of Maryland School of Medicine via AP)
Instructions
AP PROVIDES ACCESS TO THIS THIRD PARTY PHOTO SOLELY TO ILLUSTRATE NEWS REPORTING OR COMMENTARY ON FACTS DEPICTED IN IMAGE; MUST BE USED WITHIN 14 DAYS FROM TRANSMISSION; NO ARCHIVING; NO LICENSING; MANDATORY CREDIT
License
Rights Managed
Date created
20200504
Place
BALTIMORE DEUTSCHLAND
Credit
KEYSTONE
Source
AP University of Maryland School of Medicine
Byline
Size
6016 x 4016 px
File type
JPEG